We, therefore, developed a novel osmotin-derived 9-amino-acid peptide (Os_9aa) with nine amino acids sequence (C-T-Q-G-P–C-G-P–T) and explored its therapeutic potential against NSE-hαSyn/MPTP-induced PD mouse models. The gene discussed is ENO2; the disease is Parkinson disease.